SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-14-006848
Filing Date
2014-09-23
Accepted
2014-09-23 17:10:57
Documents
5
Period of Report
2014-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k091714_soligenix.htm 8-K 33702
2 CONTRACT HHSN272201400039C f8k091714ex10i_soligenix.htm EX-10.1 762680
3 PRESS RELEASE f8k091714ex99i_soligenix.htm EX-99.1 25340
4 GRAPHIC image_001.jpg GRAPHIC 52368
5 GRAPHIC firstpage.jpg GRAPHIC 801724
  Complete submission text file 0001213900-14-006848.txt   2000156
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 141116602
SIC: 2834 Pharmaceutical Preparations